Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects

NCT01827904 is registered in ClinicalTrials.gov with InSightec as lead sponsor.

NCT NCT01827904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01827904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects
Lead sponsor
InSightec
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2013
Completion date
February 24, 2021
Enrollment
76 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

essential tremor